Echocardiographic diagnoses in HIV-infected patients presenting with cardiac symptoms at Muhimbili National Hospital in Dar es Salaam, Tanzania

Cardiovascular Journal of Africa

Volumn 23, Issue 2, 2012, Pages 90-97

  Chillo, Pilly ^a   Bakari, Muhammad ^a   Lwakatare, Johnson ^a  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

Echocardiographic diagnoses in HIV; HIV and cardiac symptoms

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONGESTIVE CARDIOMYOPATHY; CROSS-SECTIONAL STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PROSPECTIVE STUDY; PULMONARY HYPERTENSION;

ADOLESCENT; ADULT; AGED; FEMALE; HEART DISEASES; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TANZANIA; YOUNG ADULT;

EID: 84859094463     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2011-060     Document Type: Article

References (44)

1. Herskowitz A, Wu TC, Willoughby SB, Vlahov D, Ansari AA, Beschorner WE, et al. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol 1994; 24(4): 1025-1032. (Pubitemid 24306414)
2. Lewis W. AIDS: cardiac findings from 115 autopsies. Prog Cardiovasc Dis 1989; 32(3): 207-215. (Pubitemid 19274896)
3. Boccara F. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors. Aids 2008; 22(3): S19-26.
4. Cegielski JP, Lwakatare J, Dukes CS, Lema LE, Lallinger GJ, Kitinya J, et al. Tuberculous pericarditis inTanzanian patients with and without HIV infection. Tuber Lung Dis 1994; 75(6): 429-434.
5. Hakim JG, Matenga JA, Siziya S. Myocardial dysfunction in human immunodeficiency virus infection: an echocardiographic study of 157 patients in hospital in Zimbabwe. Heart 1996; 76(2): 161-165. (Pubitemid 26258744)
6. Longo-Mbenza B, Tonduangu K, Muvova D, Phuati MB, Seghers KV, Kestelot H. [A clinical study of cardiac manifestations related to acquired immunodeficiency syndrome (AIDS) in Kinsaha]. Arch Mal Coeur Vaiss 1995; 88(10): 1437-1443.
7. Seaberg EC, Munoz A, Lu M, Detels R, Margolick JB, Riddler SA, et al. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. Aids 2005; 19(9): 953-960. (Pubitemid 40834939)
8. Gazzaruso C, Bruno R, Garzaniti A, Giordanetti S, Fratino P, Sacchi P, et al. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome. J Hypertens 2003; 21(7): 1377-1382.
9. Twagirumukiza M, Nkeramihigo E, Seminega B, Gasakure E, Boccara F, Barbaro G. Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: a multicenter, observational, prospective, cohort study in Rwanda. Curr HIV Res 2007; 5(1): 129-137. (Pubitemid 46062366)
10. Magula NP, Mayosi BM. Cardiac involvement in HIV-infected people living in Africa: a review. Cardiovasc J S Afr 2003; 14(5): 231-237. (Pubitemid 37462995)
11. Cegielski JP, Ramiya K, Lallinger GJ, Mtulia IA, Mbaga IM. Pericardial disease and human immunodeficiency virus in Dar es Salaam, Tanzania. Lancet 1990; 335(8683): 209-212. (Pubitemid 20054588)
12. Fleiss JL. Statistical Methods for Rates and Proportions. Oxford: John Wiley & Sons, 1973: formulae 3.18, 3.19.
13. Nzuobontane D, Blackett KN, Kuaban C. Cardiac involvement in HIV infected people in Yaounde, Cameroon. Postgrad Med J 2002; 78(925): 678-681. (Pubitemid 36090112)
14. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968; 405: 5-37.
15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7(2): 79-108. (Pubitemid 43257193)
16. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57(6): 450-458. (Pubitemid 16119719)
17. de Simone G, Devereux RB, Maggioni AP, Gorini M, de Divitiis O, Verdecchia P. Different normalizations for body size and population attributable risk of left ventricular hypertrophy: the MAVI study. Am J Hypertens 2005; 18(10): 1288-1293. (Pubitemid 41400196)
18. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. J Am Coll Cardiol 1996; 28(3): 751-756. (Pubitemid 26288660)
19. How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure. Eur Heart J 1998; 19(7): 990-1003.
20. Heidenreich PA, Eisenberg MJ, Kee LL, Somelofski CA, Hollander H, Schiller NB, et al. Pericardial effusion in AIDS. Incidence and survival. Circulation 1995; 92(11): 3229-3234.
21. Shepard C, Alexander S, Burstein S. Effusions of body cavity fluids in patients with the acquired immunodeficiency syndrome or human immunodeficiency virus infection. Acta Cytol 1991; 35: 632-633.
22. Longo-Mbenza B, Tonduangu K, Seghers KV, Mubagwa D. [HIV infection and pericardial disease invasion in Africa]. Arch Mal Coeur Vaiss 1997; 90(10): 1377-1384.
23. Mayosi BM, Wiysonge CS, Ntsekhe M, Volmink JA, Gumedze F, Maartens G, et al. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry. BMC Infect Dis 2006; 6: 2.
24. Chen Y, Brennessel D, Walters J, Johnson M, Rosner F, Raza M. Human immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature. Am Heart J 1999; 137(3): 516-521. (Pubitemid 29124121)
25. Reynolds MM, Hecht SR, Berger M, Kolokathis A, Horowitz SF. Large pericardial effusions inthe acquired immunodeficiency syndrome. Chest 1992; 102(6): 1746-1747. (Pubitemid 23001220)
26. Pugliese A, Isnardi D, Saini A, Scarabelli T, Raddino R, Torre D. Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 2000; 40(3): 282-284. (Pubitemid 30447185)
27. Aoun S, Ramos E. Hypertension inthe HIV-infected patient. Curr Hypertens Rep 2000; 2(5): 478-481.
28. Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 2001; 32(1): 130-139. (Pubitemid 32150958)
29. Bergersen BM, Sandvik L, Dunlop O, Birkeland K, Bruun JN. Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naive and HIV-negative controls: results from a Norwegian study of 721 patients. Eur J Clin Microbiol Infect Dis 2003; 22(12): 731-736. (Pubitemid 38019313)
30. Jerico C, Knobel H, Montero M, Sorli ML, Guelar A, Gimeno JL, et al. Hypertension in HIV-infected patients: prevalence and related factors. Am J Hypertens 2005; 18(11): 1396-1401. (Pubitemid 41566664)
31. Barbarinia G, Barbaro G. Incidence of the involvement of the cardiovascular system in HIV infection. Aids 2003; 17(1): S46-50. (Pubitemid 36667780)
32. Niakara A, Drabo YJ, Kambire Y, Nebie LV, Kabore NJ, Simon F. [Cardiovascular diseases and HIV infection: study of 79 cases at the National Hospital of Ouagadougou (Burkina Faso)]. Bull Soc Pathol Exot 2002; 95(1): 23-26.
33. Mesa RA, Edell ES, Dunn WF, Edwards WD. Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases. Mayo Clin Proc 1998; 73(1): 37-45. (Pubitemid 28063644)
34. Le Houssine P, Karmochkine M, Ledru F, Batisse D, Piketty C, Kazatchkine MD, et al. [Primary pulmonary hypertension in human immunodeficiency virus infection. Study of 9 cases amd review of the literature]. Rev Med Interne 2001; 22(12): 1196-1203.
35. Barbaro G. Cardiovascular manifestations of HIV infection. Circulation 2002; 106(11): 1420-1425.
36. Currie PF, Jacob AJ, Foreman AR, Elton RA, Brettle RP, Boon NA. Heart muscle disease related to HIV infection: prognostic implications. Br Med J 1994; 309(6969): 1605-1607.
37. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med 1998; 339(16): 1093-1099. (Pubitemid 28465756)
38. Watkins DA, Mayosi BM. The contribution of South Africans to the subject of dilated cardiomyopathy. With reference to: Cardiovascular collagenosis with parietal endocardial thrombosis. A clinicopathologic study of forty cases. Cardiovasc J Afr 2009; 20(1): 11-16.
39. Suttmann U, Ockenga J, Selberg O, Hoogestraat L, Deicher H, Muller MJ. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8(3): 239-246.
40. Dworkin BM, Antonecchia PP, Smith F, Weiss L, Davidian M, Rubin D, et al. Reduced cardiac selenium content in the acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr 1989; 13(6): 644-647. (Pubitemid 20005567)
41. Kavanaugh-McHugh AL, Ruff A, Perlman E, Hutton N, Modlin J, Rowe S. Selenium deficiency and cardiomyopathy in acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr 1991; 15(3): 347-349.
42. Chetty R, Batitang S, Nair R. Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Hum Pathol 2000; 31(3): 374-379. (Pubitemid 30161358)
43. Sinzobahamvya N, Kalangu K, Hamel-Kalinowski W. Arterial aneurysms associated with human immunodeficiency virus (HIV) infection. Acta Chir Belg 1989; 89(4): 185-188. (Pubitemid 19239090)
44. Chetty R. Vasculitides associated with HIV infection. J Clin Pathol 2001; 54(4): 275-278. (Pubitemid 32270009)